Schizophrenia, syndrome X, and omega-3 fatty acids.
François
F
Pouwer
Ritsaert
R
Lieverse
Michaela
M
Diamant
Johanna
J
Assies
D015897:Comorbidity; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000378:metabolism / Q000517:prevention & control*; D012559:Schizophrenia / Q000178:diet therapy* / Q000453:epidemiology / Q000378:metabolism
D015525:Fatty Acids, Omega-3; D005231:Fatty Acids, Unsaturated; D015118:Eicosapentaenoic Acid